Carecubes

The company has developed and commercialized the "Carecube," a modular negative-pressure isolation chamber designed to rapidly isolate patients with airborne infectious diseases. The device meets or exceeds CDC standards for Airborne Infection Isolation Rooms (AIIRs), provides 15+ air exchanges per hour using HEPA filtration, and has undergone rigorous third-party testing. It received FDA 510(k) clearance in the US.

Clinical results are not applicable as this is a medical device rather than a therapeutic intervention.

The product was co-developed with input from experts at CDC, ASPR, DARPA, and University of Nebraska Medical Center.

Used during COVID‑19 pandemic response; designed to improve safety for both patients and healthcare providers by reducing reliance on PPE while maintaining high levels of infection control.